10-K: Morgan Stanley Reports Record 2025 Earnings, Boosts Dividends
Annual Report
Morgan Stanley announced robust financial results for the year ended December 31, 2025, with significant increases in net revenues, net income, and diluted earnings per share, alongside improved efficiency and capital strength.
Summary
- Net revenues for 2025 increased by 14% to $70.6 billion, up from $61.8 billion in 2024.
- Net income applicable to Morgan Stanley rose by 26% to $16.9 billion in 2025, compared to $13.4 billion in 2024.
- Diluted earnings per common share reached $10.21 in 2025, a 28% increase from $7.95 in 2024.
- The firm's Return on Average Common Equity (ROE) improved to 16.6% in 2025 from 14.0% in 2024.
- Return on Average Tangible Common Equity (ROTCE) increased to 21.6% in 2025 from 18.8% in 2024, surpassing the firm's 20% goal.
- The expense efficiency ratio improved to 68% in 2025, down from 71% in the prior year.
- Institutional Securities net revenues grew by 18% to $33.1 billion, driven by strong Equity performance and higher Investment Banking underwriting and Advisory revenues.
- Wealth Management net revenues increased by 12% to $31.8 billion, primarily due to higher Asset management revenues from market levels and positive fee-based flows, achieving a pre-tax margin of 29.3%.
- Wealth Management recorded $160 billion in fee-based asset flows and $356 billion in net new assets.
- Investment Management net revenues increased by 11% to $6.5 billion, mainly from higher asset management fees and performance-based income.
- The Standardized Common Equity Tier 1 capital ratio was 15.0% and the Supplementary Leverage Ratio (SLR) was 5.4% as of December 31, 2025.
- The firm repurchased $4.585 billion of common stock in 2025, and the Board reauthorized a multi-year repurchase program of up to $20 billion.
- A quarterly common stock dividend of $1.00 per share was announced on January 15, 2026, an increase from $0.925.
- The Stress Capital Buffer (SCB) was reduced from 5.1% to 4.3%, effective October 1, 2025.
- Penalty orders totaling €101 million (approximately $117 million) were imposed on two subsidiaries by Dutch criminal authorities for filing false tax returns for 2007-2012, which were paid in Q4 2025.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a very positive report, driven by strong financial performance across all key metrics and business segments, coupled with favorable capital management actions. While ongoing legal and regulatory matters present some headwinds, the overall operational strength and strategic execution are highly encouraging.
Positives
- Net revenues increased by 14% to $70.6 billion, reflecting strong performance across all business segments.
- Net income applicable to Morgan Stanley grew by 26% to $16.9 billion, demonstrating robust profitability.
- Diluted earnings per common share increased by 28% to $10.21.
- Return on average common equity (ROE) improved to 16.6%, and Return on average tangible common equity (ROTCE) reached 21.6%, exceeding the firm's 20% goal.
- The expense efficiency ratio improved to 68%, indicating better operational leverage.
- Wealth Management achieved significant growth with $356 billion in net new assets and $160 billion in fee-based asset flows.
- Institutional Securities saw strong performance in Equity (28% increase in net revenues) and Investment Banking (23% increase in revenues).
- The Stress Capital Buffer (SCB) was reduced from 5.1% to 4.3%, effective October 1, 2025, indicating improved regulatory capital standing.
- The firm elected to early adopt modified eSLR standards, resulting in a lower SLR standard of 3.5% (inclusive of a 0.5% eSLR buffer) from April 1, 2026, compared to the prior 5.0% standard.
- The Board reauthorized a multi-year share repurchase program of up to $20 billion, signaling confidence in future performance and commitment to shareholder returns.
- The quarterly common stock dividend was increased to $1.00 per share, reflecting strong capital generation.
Negatives
- The provision for credit losses increased to $349 million in 2025 from $264 million in 2024, primarily due to portfolio growth in corporate loans and secured lending facilities, and provisions for certain specific commercial real estate loans.
- Institutional Securities Other Net Revenues decreased by 12% due to lower net interest income and fees following the sale of corporate loans held-for-sale.
- Commodities products and other fixed income revenues decreased primarily due to lower gains on inventory held to facilitate client activity in power and gas.
- Wealth Management Other Net Revenues decreased by 15% compared to the prior year.
- Wealth Management Net Interest revenues were impacted by the net effect of lower interest rates, partially offset by lending growth and changes in balance sheet mix.
- Investment Management experienced continued net outflows in the Equity asset class, which may impact future asset management revenue.
- The G-SIB Surcharge is estimated to potentially increase from 3.0% to 3.5% in the future, though this change would not take effect before January 1, 2028.
- Dutch criminal authorities imposed penalty orders totaling €101 million (approximately $117 million) on two subsidiaries for filing false tax returns for 2007-2012, which were paid in Q4 2025.
- The firm is a defendant in ongoing antitrust class action complaints regarding alleged efforts to artificially inflate interest rates for Variable Rate Demand Obligations (VRDO).
- Multiple putative class actions are pending against subsidiaries (MSSB and E*TRADE Securities) alleging failure to pay reasonable interest rates on cash sweep products.
Risks
- Market risk from fluctuations in global equity, fixed income, currency, credit, and commodities markets, including corporate, commercial, and residential mortgage lending, real estate, and energy markets.
- Results of operations may be materially affected by global financial market and economic conditions, including periods of low or slowing economic growth, interest rate volatility, inflation, and geopolitical uncertainty.
- Difficulty in valuing and monetizing certain financial instruments, particularly during periods of market uncertainty or illiquidity, potentially leading to significant changes in value and adverse impacts on fees and performance-based income.
- Significant changes to interest rates could adversely affect net interest income, client preferences, cash allocation, and loan demand.
- Holding large and concentrated positions may expose the firm to larger losses in market-making, investing, underwriting, and lending businesses.
- Credit risk arising from borrowers, counterparties, or issuers not meeting their financial obligations, including from lending commitments, derivative contracts, clearing broker activities, and investments in securities/loan pools.
- Inaccurate valuations or reserves for credit exposures due to complex models, estimates, subjective judgments, or external factors like geopolitical events or changes in trade policies.
- Systemic risk from the commercial soundness of many financial institutions being interrelated, potentially leading to market-wide liquidity and credit problems or defaults.
- Operational risks, including loss or damage from inadequate or failed processes/systems, human factors (e.g., misconduct), or external events (e.g., cyberattacks, third-party vulnerabilities), which can manifest as business disruption, theft, fraud, or legal/regulatory risks.
- Increased reliance on complex technology and automated trading platforms, and the introduction of new technologies like generative artificial intelligence and tokenization, may increase operational risks and pressure on revenues.
- Cybersecurity threats, information or security breaches, or technology failures of the firm or third parties, which could lead to disclosure or misuse of sensitive information, business disruption, reputational harm, regulatory investigations, and financial penalties.
- Exposure to numerous political, economic, legal, compliance, tax, operational, and franchise risks from international operations, including nationalization, expropriation, capital controls, increased taxes, and regulatory scrutiny.
- Inability to fully capture the expected value from acquisitions, divestitures, joint ventures, partnerships, minority stakes, or strategic alliances, or exposure to new or increased risks from such initiatives.
- Climate-related physical risks (e.g., floods, hurricanes) and transition risks (e.g., policy changes, market shifts) could result in increased costs, adversely affect operations and clients, and lead to reputational harm.
- Risk management strategies, models, and processes may not be fully effective in mitigating all risk exposures, especially for extreme market events or unidentified risks.
- Dependence on payments from subsidiaries, which may be limited by regulatory restrictions or legal requirements.
- Borrowing costs and access to debt capital markets are dependent on credit ratings, and downgrades could require additional collateral or immediate settlement of liabilities.
- The application of regulatory requirements and strategies, such as the Single Point of Entry (SPOE) resolution strategy and Total Loss-Absorbing Capacity (TLAC) requirements, may pose a greater risk of loss for security holders.
- Regulatory constraints or revised regulatory capital requirements may prevent the firm from paying dividends or taking other capital actions.
- Substantial litigation and extensive regulatory and law enforcement investigations could lead to damage to reputation and significant legal liability.
- Failure to address conflicts of interest appropriately could adversely affect businesses and reputation.
- Strong competition from financial services firms and others could lead to pricing pressures and adversely affect revenues and profitability.
- Inability to retain and attract qualified employees is critical to business success and could materially adversely affect performance.
Future Outlook
Morgan Stanley expects to remain subject to extensive supervision and regulation, with the impact of proposed revisions to capital requirements remaining uncertain. The G-SIB Surcharge is estimated to potentially increase from 3.0% to 3.5% in the future, though this change would not take effect before January 1, 2028. The current Stress Capital Buffer (SCB) of 4.3% is expected to remain in effect until October 1, 2027. Net interest income may be impacted in future periods by interest rate changes, competitive dynamics, and client preferences. The firm's ROTCE goal of 20% is a forward-looking statement based on a normal market environment, and continued net outflows in the Equity asset class may impact Investment Management's asset management revenue. The ultimate impact of climate-related risks is difficult to assess due to evolving factors.
Management Comments
- The Firm reported net revenues of $70.6 billion and net income applicable to Morgan Stanley of $16.9 billion reflecting strong results across our business segments and demonstrating the strength of our Integrated Firm.
- The Firm delivered ROE of 16.6% and ROTCE of 21.6%.
- The Firm expense efficiency ratio was 68% compared to 71% in the prior year, demonstrating operating leverage while continuing to invest in our businesses.
- Institutional Securities net revenues of $33.1 billion, primarily reflecting strong performance in Equity on higher client activity and higher underwriting and Advisory revenues within Investment Banking.
- Wealth Management delivered net revenues of $31.8 billion, primarily reflecting higher Asset management revenues on higher market levels and the cumulative impact of strong fee-based flows. The pre-tax margin was 29.3%. Fee-based asset flows were $160 billion and the business added net new assets of $356 billion.
- Investment Management reported net revenues of $6.5 billion, primarily reflecting higher asset management fees driven by higher average AUM on higher market levels.
- We believe effective risk management is vital to the success of our business activities.
- Our ROTCE goal is a forward-looking statement that is based on a normal market environment and may be materially affected by many factors.
- We believe current valuations and reserves adequately address our perceived levels of risk.
- We believe that the estimates utilized in the preparation of its financial statements are prudent and reasonable.
- The Firm believes there are no securities in an unrealized loss position that have credit losses after performing the analysis described in Note 2. Additionally, the Firm does not intend to sell these securities and is not likely to be required to sell these securities prior to recovery of the amortized cost basis.
- The Firm believes the recognized net deferred tax assets (after valuation allowance) at December 31, 2025 are more likely than not to be realized based on expectations as to future taxable income in the jurisdictions in which it operates.
- The Firm believes that the resolution of these tax examinations will not have a material effect on the annual financial statements, although a resolution could have a material impact in the income statement and on the effective tax rate for any period in which such resolutions occur.
- The Firm believes the likelihood of any payment by the Firm under these arrangements is remote given the level of its due diligence in its role as investment banking advisor.
- Management believes that the risk of material loss to the Firm is expected to be remote.
Industry Context
StockSavvy.ai notes that Morgan Stanley's strong financial performance in 2025, particularly in Investment Banking and Equity trading, aligns with a resilient economic environment characterized by improved client and investor confidence and increased capital markets activity. The firm's significant growth in Wealth Management client assets and net new assets demonstrates its ability to compete effectively against both established financial services firms and emerging fintech companies. The ongoing regulatory landscape, including evolving capital requirements (Basel III, TLAC, eSLR) and heightened cybersecurity focus, represents industry-wide challenges that Morgan Stanley, as a Global Systemically Important Bank (G-SIB), continues to navigate. The firm's 'Integrated Firm' strategy is a common approach among large financial institutions to leverage synergies across business segments and enhance client relationships.
Comparison to Industry Standards
- Morgan Stanley's ROTCE of 21.6% in 2025 exceeded its internal goal of 20%, indicating strong performance relative to its own strategic benchmarks.
- The firm's Liquidity Coverage Ratio (LCR) of 134% and Net Stable Funding Ratio (NSFR) of 121% as of December 31, 2025, are both above the minimum regulatory requirement of 100%, demonstrating robust liquidity compared to industry standards.
- The reduction of Morgan Stanley's Stress Capital Buffer (SCB) from 5.1% to 4.3% (effective October 1, 2025) reflects an improved position within the Federal Reserve's supervisory stress testing framework compared to other large Bank Holding Companies (BHCs).
- The early adoption of modified Enhanced Supplementary Leverage Ratio (eSLR) standards, resulting in a 3.5% SLR standard, aligns Morgan Stanley with the updated regulatory benchmarks for U.S. G-SIBs.
- The firm's capital ratios (CET1, Tier 1, Total Capital) under both Standardized and Advanced Approaches consistently exceeded regulatory minimums plus capital conservation buffer requirements, indicating strong capital adequacy relative to Basel III standards.
- The filing notes that 'VaR statistics are not readily comparable across firms because of differences in the firms portfolios, modeling assumptions and methodologies,' highlighting the challenge of direct peer comparison using this metric.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Client Officer | Chief Human Resources Officer | Mandell L. Crawley | January 2025 | Role change from Chief Human Resources Officer. |
| Chief Administrative Officer | NA | Eric F. Grossman | July 2022 | Assumed additional role. |
| Chairman of the Board of Directors | NA | Edward Pick | January 2025 | Assumed additional role. |
| Chief Executive Officer | NA | Edward Pick | January 2024 | Promotion from Co-President and Co-Head of Corporate Strategy, and Head of Institutional Securities. |
| Head of Technology and Operations | Head of U.S. Banks and Head of Technology | Michael A. Pizzi | January 2025 | Role change from Head of U.S. Banks and Head of Technology. |
| Co-President | Head of Wealth Management | Andrew M. Saperstein | June 2021 | Promotion from Head of Wealth Management. |
| Co-President | Head of Investment Management and Co-Head of Corporate Strategy | Daniel A. Simkowitz | January 2024 | Promotion from Head of Investment Management and Co-Head of Corporate Strategy. |
| Chief Risk Officer | Head of Institutional Securities Business Development | Charles A. Smith | May 2023 | Promotion from Head of Institutional Securities Business Development. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Update | The Morgan Stanley 401(k) Plan was amended effective January 1, 2025, to exclude special one-time payments (generally not to exceed $1,000) from the definition of Earnings. Further amended effective January 1, 2026, to require Designated Highly Compensated Employees to make catch-up contributions as Roth after-tax contributions, which will not be treated as Matched Contributions. | January 1, 2025 and January 1, 2026 | These amendments adjust the calculation of eligible earnings and the nature of catch-up contributions for certain employees, potentially impacting retirement savings strategies and employer matching contributions for Designated Highly Compensated Employees. |
| Plan Termination | The Tax Deferred Equity Participation Plan and the Employees Equity Accumulation Plan were terminated. | March 31, 2025 | These terminations conclude certain deferred compensation arrangements, potentially shifting employee compensation structures towards other existing plans like RSUs, PSUs, or the ESPP. |
| Policy Update | The Directors Equity Capital Accumulation Plan was amended and restated. | November 1, 2024 | This update likely refines the terms under which non-employee directors receive stock units and defer cash fees, impacting their equity compensation structure. |
| Policy Update | The Morgan Stanley Equity Incentive Compensation Plan was amended and restated. | March 31, 2025 | This amendment likely updates the framework for granting stock options, stock appreciation rights, restricted stock, restricted stock units, performance-based units, and other equity-based awards, affecting employee incentive compensation. |
| Policy Update | The Morgan Stanley Compensation Incentive Plan was amended and restated. | December 16, 2024 | This update likely refines the terms of the firm's compensation incentive plan, influencing how discretionary retention awards and other incentives are structured and granted. |
| Policy Update | The Global Policy for Transactions in Morgan Stanley Securities is in place. | NA | This policy is designed to promote compliance with insider trading laws, rules, and regulations, enhancing ethical conduct and regulatory adherence for transactions in firm securities. |
| Committee Oversight | The Board of Directors oversees the Enterprise Risk Management (ERM) framework, financial performance, strategy, business plans, reputational and franchise risk, and culture, values, and conduct. | Ongoing | Ensures comprehensive oversight of the firm's strategic direction, risk profile, and ethical standards at the highest level of governance. |
| Committee Oversight | The Risk Committee of the Board (BRC) assists in ERM oversight, oversees significant financial risk exposures (market, credit, model, liquidity), risk appetite, capital and liquidity planning, new product risk, emerging risks, regulatory matters, and climate risk. | Ongoing | Provides specialized oversight of critical financial and emerging risks, ensuring alignment with the firm's risk appetite and regulatory requirements. |
| Committee Oversight | The Audit Committee of the Board (BAC) oversees the integrity of financial statements, compliance with legal and regulatory requirements, internal controls, and major legal, compliance, and financial crime risk exposures. | Ongoing | Enhances financial reporting integrity, regulatory compliance, and internal control effectiveness, crucial for investor confidence and risk mitigation. |
| Committee Oversight | The Operations and Technology Committee of the Board (BOTC) oversees operations and technology strategy, significant investments, and operational risk, including IT, information security, fraud, third-party oversight, business disruption, resilience, and cybersecurity risks. | Ongoing | Provides dedicated oversight for critical operational and technology risks, which are increasingly important in the financial services industry, especially concerning cybersecurity and new technologies. |
| Management Framework | The Firm Risk Committee (FRC), a management committee, oversees the ERM framework, risk management principles, procedures, limits, and tolerances, and monitors capital levels and material risks. | Ongoing | Ensures a consistent and comprehensive approach to risk management across the firm, integrating risk assessment into decision-making processes. |
| Policy Update | The Global Conduct Risk Management Policy sets out a consistent global framework for managing conduct risk and conduct risk incidents. | Ongoing | Reinforces the firm's commitment to integrity and ethical conduct, aiming to mitigate risks arising from employee misconduct. |
Legal Proceedings
- In Re: Interest Rate Swaps Antitrust Litigation: Class claims were settled, and final approval of the settlement was granted on July 17, 2025. Claims brought by three swap execution facility operators remain pending.
- City of Philadelphia, et al. v. Bank of America Corporation, et al. (VRDO Antitrust): The court granted plaintiffs' motion for class certification on September 21, 2023, which was affirmed by the Second Circuit on August 1, 2025. Defendants filed a petition for writ of certiorari with the U.S. Supreme Court on December 1, 2025.
- Dutch Tax Authority Challenges: The firm reached an agreement to settle challenges for tax years 2007-2012 on November 11, 2024. Penalty orders totaling €101 million (approximately $117 million) were imposed on Morgan Stanley Derivatives Products (Netherlands) B.V. and Morgan Stanley & Co. International plc for filing false tax returns for 2007-2012, which were paid in the fourth quarter of 2025.
- U.K. Government Bond Matter: The firm reached a settlement with the U.K. Competition and Markets Authority on February 21, 2025, regarding suspected anti-competitive arrangements. Separately, a U.S. class action complaint was dismissed without prejudice on September 16, 2024, and an agreement in principle to settle the U.S. litigation was reached in October 2024, with preliminary approval granted on March 17, 2025.
- IKB International S.A. in Liquidation, et al. v. Morgan Stanley, et al.: The case was dismissed on August 28, 2024, with judgment entered in the firm's favor. The plaintiff has appealed this decision.
- Estate of Sherlip, et al. v. Morgan Stanley, et al. (Cash Sweep Litigation): Multiple putative class actions alleging failure to pay reasonable interest rates on cash sweep products have been consolidated. An amended complaint was filed on August 15, 2025, and MSSB moved to dismiss it on September 12, 2025. A consolidated action in the District of New Jersey is pending the appointment of lead counsel.
- The firm is responding to requests from state securities regulators regarding brokerage account cash balances swept to the affiliate bank deposit program.
Related Party Transactions
- Morgan Stanley Finance LLC (MSFL), a wholly-owned finance subsidiary, issues Series A senior debt securities that are fully and unconditionally guaranteed by Morgan Stanley.
- The firm and Mitsubishi UFJ Financial Group, Inc. (MUFG) formed a joint venture in Japan, comprising Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. (MUMSS) and Morgan Stanley MUFG Securities Co., Ltd. (MSMS). The firm owns a 40% economic interest in the Joint Venture, accounting for MUMSS under the equity method, and consolidates MSMS based on its 51% voting interest.
- The firm engages in ordinary course of business transactions with MUFG and its affiliates, including investment banking, financial advisory, sales and trading, derivatives, investment management, lending, and securitization, on substantially the same terms as with unrelated third parties.
- The Parent Company has transactions with its consolidated subsidiaries on an agreed-upon basis and guarantees certain unsecured lines of credit and contractual obligations of its subsidiaries.
- The Parent Company has entered into an amended and restated support agreement with its material entities, including Morgan Stanley Holdings LLC (Funding IHC), and certain other subsidiaries, obligating the Parent Company to contribute assets to supported entities in a resolution scenario, with these obligations generally secured on a senior basis by the Parent Company's assets.
Stakeholder Impact
- Shareholders: Benefited from increased earnings, ROE, ROTCE, share repurchases, and an increased common stock dividend. However, the SPOE resolution strategy could result in greater losses for holders of Parent Company securities compared to creditors of supported subsidiaries in a resolution scenario.
- Employees: Experienced increased compensation and benefits, including higher discretionary incentive compensation. A workforce management action in March 2025 resulted in severance costs for approximately 2% of the global workforce. Deferred cash-based compensation plans provide investment-linked returns, and the firm continues to invest in talent development and wellbeing programs.
- Clients: Benefited from strong performance in Institutional Securities (Equity, Investment Banking) and Wealth Management (asset management, transactional revenues), leading to increased client assets and net new assets. Clients are impacted by the firm's various lending and trading services, and some are involved in ongoing legal proceedings related to cash sweep products.
- Creditors: Holders of eligible long-term debt and other Total Loss-Absorbing Capacity (TLAC) issued by the Parent Company would absorb losses before creditors of supported subsidiaries in an SPOE resolution. The firm's credit ratings influence borrowing costs and access to debt markets.
- Regulators: The firm is subject to extensive regulation and ongoing scrutiny, including capital, liquidity, and resolution planning requirements. Compliance with various laws (AML, sanctions, anti-corruption) is critical, and regulatory actions, such as the Dutch penalty orders, highlight the consequences of non-compliance.
Next Steps
- Monitor the changing political, tax, and regulatory environment for potential impacts on business, financial condition, and results of operations.
- Address any deficiencies identified by the Federal Reserve and FDIC in the resolution plan, with the next resolution plan due July 2027.
- Submit an annual recovery plan to the Federal Reserve outlining steps to generate or conserve financial resources during prolonged financial stress.
- Provide updated information on applicable regulatory capital standards in response to final rulemakings, particularly concerning proposed changes to capital requirements and supervisory stress testing.
- Continue to make investments in cybersecurity, resilience, and information security posture to address evolving threats and comply with regulatory requirements.
- Continue to evaluate the Required Capital framework with respect to the impact of evolving regulatory requirements.
- Continue efforts to attract, integrate, and retain qualified employees, and invest in talent development and diversity initiatives.
- Actively monitor and manage market, credit, liquidity, operational, model, legal, regulatory, compliance, and climate risks through established frameworks and processes.
- Evaluate the disclosure impact of new accounting updates (ASU 2024-03, ASU 2025-06, ASU 2025-07, ASU 2025-08, ASU 2025-09, ASU 2025-10, ASU 2025-11) and implement necessary changes upon adoption.
Key Dates
| Date | Description |
|---|---|
| 1981 | Morgan Stanley originally incorporated under the laws of the State of Delaware. |
| September 30, 1997 | Date for BHC Act grandfather exemption for commodities activities. |
| May 1, 1999 | Date of Amended and Restated Senior Indenture. |
| October 1, 2004 | Date of Subordinated Indenture. |
| November 1, 2004 | Date of Senior Indenture. |
| November 22, 2005 | Date of Form of Restrictive Covenant Agreement. |
| January 2006 | Eric F. Grossman became Global Head of Litigation. |
| July 5, 2006 | Date of Registration Statement on Form 8-A for Series A Preferred Stock. |
| July 6, 2006 | Date of Deposit Agreement for Series A Preferred Stock. |
| October 12, 2006 | Date of Junior Subordinated Indenture. |
| September 4, 2007 | Date of First Supplemental Senior Indenture. |
| October 8, 2007 | Date of Fourth Supplemental Senior Indenture. |
| August 29, 2008 | Date of Unit Agreement Without Holders Obligations. |
| September 10, 2008 | Date of Third Supplemental Senior Indenture. |
| December 1, 2008 | Date of Fourth Supplemental Senior Indenture. |
| December 31, 2008 | Effective date of amended and restated Morgan Stanley Supplemental Executive Retirement and Excess Plan. |
| April 2009 | Edward Pick became Co-Head of Global Equities. |
| November 2009 | Daniel A. Simkowitz became Chairman of Global Capital Markets. |
| September 2010 | Eric F. Grossman became Global Head of Legal. |
| July 15, 2011 | Earliest optional redemption date for Series A Preferred Stock. |
| September 16, 2011 | Date of Sixth Supplemental Senior Indenture. |
| November 21, 2011 | Date of Seventh Supplemental Senior Indenture. |
| January 2012 | Eric F. Grossman became Chief Legal Officer. |
| May 4, 2012 | Date of Eighth Supplemental Senior Indenture. |
| June 2012 | Andrew M. Saperstein became Head of Investment Products and Services. |
| August 2012 | Charles A. Smith became Chief Financial Officer of Institutional Securities. |
| May 17, 2013 | IKB International S.A. in Liquidation, et al. v. Morgan Stanley, et al. complaint filed. |
| September 27, 2013 | Date of Registration Statement on Form 8-A for Series E Preferred Stock. |
| March 10, 2014 | Date of Ninth Supplemental Senior Indenture. |
| September 17, 2014 | Date of Registration Statement on Form 8-A for Series I Preferred Stock. |
| January 2015 | Sharon Yeshaya became Chief of Staff in the Office of the Chairman and CEO. |
| March 2015 | Andrew M. Saperstein became Co-Chief Operating Officer of Institutional Securities. |
| October 2015 | Daniel A. Simkowitz became Head of Investment Management. |
| January 2016 | Andrew M. Saperstein became Co-Head of Wealth Management. |
| February 16, 2016 | Date of MSFL Senior Debt Indenture. |
| February 22, 2016 | MSFL issued Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes Due 2026. |
| February 23, 2016 | Interest payment commencement date for 2026 Notes. |
| February 2016 | Firm named as defendant in In Re: Interest Rate Swaps Antitrust Litigation. |
| January 11, 2017 | Date of Tenth Supplemental Senior Indenture. |
| January 30, 2017 | Date of Registration Statement on Form 8-A for Series K Preferred Stock. |
| March 2017 | Charles A. Smith became Head of Institutional Securities Business Development. |
| June 2017 | Mandell L. Crawley became Head of Private Wealth Management. |
| July 28, 2017 | Court granted in part and denied in part motion to dismiss in In Re: Interest Rate Swaps Antitrust Litigation. |
| January 1, 2018 | Amended and Restated Trust Agreement dated. |
| July 2018 | Edward Pick became Head of Institutional Securities. |
| August 2019 | Michael A. Pizzi became Chief Executive Officer of E*TRADE Financial Corporation. |
| November 22, 2019 | Date of Registration Statement on Form 8-A for Series L Preferred Stock. |
| September 15, 2020 | Dividend period start for Series N Preferred Stock (5.30% fixed rate). |
| October 2, 2020 | MSFL issued Global Medium-Term Notes, Series A, Floating Rate Notes Due 2029. Earliest optional redemption date for Series N Preferred Stock. |
| October 2020 | Michael A. Pizzi became Head of Digital Direct and CoHead of Equity Administration for Wealth Management. |
| February 2021 | Mandell L. Crawley became Executive Vice President and Chief Human Resources Officer. |
| March 24, 2021 | Date of Eleventh Supplemental Senior Indenture. |
| June 2021 | Sharon Yeshaya became Chief Financial Officer. Andrew M. Saperstein became Co-President. Edward Pick became Co-President and Co-Head of Corporate Strategy. Daniel A. Simkowitz became Co-Head of Corporate Strategy. Michael A. Pizzi became Chairman and CEO of Morgan Stanley Private Bank, National Association and Morgan Stanley Bank, N.A. |
| October 22, 2021 | Date of Registration Statement on Form 8-A for Series O Preferred Stock. |
| July 15, 2022 | Firm filed motion for summary judgment in IKB International S.A. in Liquidation, et al. v. Morgan Stanley, et al. |
| July 2022 | Eric F. Grossman became Chief Administrative Officer. |
| August 1, 2022 | Date of Registration Statement on Form 8-A for Series P Preferred Stock. Amended and restated Employee Stock Purchase Plan. |
| January 2023 | Michael A. Pizzi became Head of U.S. Banks and Head of Technology. |
| March 1, 2023 | Court granted in part and denied in part motion for summary judgment in IKB International S.A. in Liquidation, et al. v. Morgan Stanley, et al. |
| March 15, 2023 | Series N Preferred Stock transitioned to floating rate. |
| May 2023 | Charles A. Smith became Chief Risk Officer. |
| June 30, 2023 | Three-month U.S. dollar LIBOR ceased publication on a representative basis. |
| September 21, 2023 | Court granted plaintiffs motion for class certification in City of Philadelphia, et al. v. Bank of America Corporation, et al. |
| October 15, 2023 | Earliest optional redemption date for Series E Preferred Stock. |
| December 15, 2023 | Court denied class plaintiffs motion for class certification in In Re: Interest Rate Swaps Antitrust Litigation. |
| January 2024 | Edward Pick became Chief Executive Officer. Daniel A. Simkowitz became Co-President. |
| January 1, 2024 | Firm adopted ASU 2023-07 (Segment Reporting) and ASU 2023-02 (Tax Credit Structures) retrospectively. |
| January 15, 2024 | Earliest optional redemption date for Series F Preferred Stock. |
| February 5, 2024 | Second Circuit granted leave to appeal class certification decision in City of Philadelphia, et al. v. Bank of America Corporation, et al. |
| February 2024 | MSSB and E*TRADE Securities named as defendants in multiple putative class actions regarding cash sweep products. |
| February 28, 2024 | Parties reached an agreement in principle to settle class claims in In Re: Interest Rate Swaps Antitrust Litigation. |
| March 26, 2024 | Appellate Division affirmed trial court's summary judgment order in IKB International S.A. in Liquidation, et al. v. Morgan Stanley, et al. |
| October 2024 | Firm and certain other defendants reached an agreement in principle to settle the U.S. litigation in the U.K. Government Bond Matter. |
| November 1, 2024 | Directors Equity Capital Accumulation Plan amended and restated. |
| November 11, 2024 | Firm reached an agreement to settle the Dutch Tax Authority's challenges for the tax years 2007 to 2012. |
| November 24, 2024 | ASU 2024-03 Disaggregation of Income Statement Expenses issued. |
| December 16, 2024 | Morgan Stanley Compensation Incentive Plan amended and restated. |
| January 1, 2025 | Effective date of amendment to Morgan Stanley 401(k) Plan. Effective date of ASU 2023-09 (Income Tax Disclosures) and ASU 2023-02 (Tax Credit Structures). |
| January 15, 2025 | Special one-time payment to certain employees. Earliest optional redemption date for Series L Preferred Stock. |
| February 21, 2025 | U.K. Competition and Markets Authority announced a settlement with the Firm in connection with its investigation of suspected anti-competitive arrangements in the financial services sector. |
| March 17, 2025 | Court granted preliminary approval of the settlement in the U.K. Government Bond Matter. |
| March 31, 2025 | Tax Deferred Equity Participation Plan and Employees Equity Accumulation Plan terminated. Morgan Stanley Equity Incentive Compensation Plan amended and restated. |
| April 7, 2025 | Capital plan and company-run stress test results submitted to the Federal Reserve. |
| April 17, 2025 | Federal Reserve proposed revisions to the SCB and CCAR frameworks. |
| July 1, 2025 | Board reauthorized a multi-year share repurchase program of up to $20 billion. |
| July 16, 2025 | Quarterly common stock dividend increased to $1.00 per share. |
| July 17, 2025 | Court granted final approval of the settlement in In Re: Interest Rate Swaps Antitrust Litigation. |
| August 1, 2025 | Second Circuit affirmed the class certification decision in City of Philadelphia, et al. v. Bank of America Corporation, et al. |
| August 15, 2025 | Amended class action complaint filed in Estate of Sherlip, et al. v. Morgan Stanley, et al. |
| August 27, 2025 | Plaintiff in IKB International S.A. in Liquidation, et al. v. Morgan Stanley, et al. notified the court of inability to prove claims and requested dismissal. |
| August 28, 2025 | Court dismissed IKB International S.A. in Liquidation, et al. v. Morgan Stanley, et al., with judgment entered in the Firm's favor. |
| September 2025 | ASU 2025-06 Internal-Use Software and ASU 2025-07 Derivatives Scope Refinements and Share-Based Consideration from a Customer issued. |
| September 12, 2025 | MSSB moved to dismiss the complaint in Estate of Sherlip, et al. v. Morgan Stanley, et al. |
| September 30, 2025 | Dutch Public Prosecutor served indictments on Firm subsidiaries. Federal Reserve announced reduced SCB from 5.1% to 4.3%. |
| October 1, 2025 | Reduced SCB of 4.3% became effective. |
| October 15, 2024 | Earliest optional redemption date for Series I Preferred Stock. |
| October 24, 2025 | Federal Reserve proposed revisions to its supervisory stress testing framework. |
| November 2025 | ASU 2025-08 Purchased Loans and ASU 2025-09 Hedge Accounting Improvements issued. |
| November 25, 2025 | U.S. banking agencies adopted a final rule modifying eSLR standards. |
| November 27, 2025 | Dutch Public Prosecutor announced the imposition of penalty orders totaling €101 million (approximately $117 million) on Morgan Stanley Derivatives Products (Netherlands) B.V. and Morgan Stanley & Co. International plc. |
| December 1, 2025 | Defendants filed a petition for writ of certiorari with the United States Supreme Court regarding the Second Circuit's August 2025 decision in the VRDO antitrust case. |
| December 9, 2025 | Amendment to the Morgan Stanley 401(k) Plan executed. |
| December 2025 | ASU 2025-10 Government Grants and ASU 2025-11 Interim Reporting issued. |
| December 31, 2025 | End of the fiscal year covered by this annual report. |
| January 1, 2026 | Effective date of amendment to Morgan Stanley 401(k) Plan. Early adoption of modified eSLR standards by the Firm and its U.S. Bank Subsidiaries. |
| January 15, 2026 | Common stock dividend of $1.00 per share announced. |
| January 2026 | MSESE became a fully licensed credit institution under the EU Capital Requirements Regulation. |
| January 30, 2026 | Record date for the $1.00 common stock dividend. |
| February 4, 2026 | Federal Reserve finalized the second proposal on supervisory stress testing and announced current SCB of 4.3% expected until October 1, 2027. |
| February 13, 2026 | Date $1.00 common stock dividend paid. |
| February 14, 2026 | Fixed income derivatives business of Morgan Stanley Capital Services LLC (MSCS) merged into MSBNA. MSCS was divided into two entities. |
| February 19, 2026 | Date of this annual report on Form 10-K. |
| February 23, 2026 | Maturity date for Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes Due 2026. |
| April 1, 2026 | Effective date of the final rule modifying eSLR standards. |
| September 15, 2026 | Earliest optional redemption date for Series M Preferred Stock. |
| January 1, 2027 | Effective date for ASU 2024-03 (Income Statement Expenses), ASU 2025-07 (Derivatives Scope Refinements), ASU 2025-08 (Purchased Loans), ASU 2025-09 (Hedge Accounting Improvements). Earliest optional redemption date for Series K and Series O Preferred Stock. |
| July 2027 | Next resolution plan due to the Federal Reserve and FDIC. |
| October 1, 2027 | New SCB requirement may apply based on the results of the supervisory stress test conducted in 2027. |
| October 15, 2027 | Earliest optional redemption date for Series P Preferred Stock. |
| January 1, 2028 | Effective date for ASU 2025-06 (Internal-Use Software) and ASU 2025-11 (Interim Reporting). Earliest potential effective date for G-SIB Surcharge increase. |
| June 27, 2029 | Maturity date for Global Medium-Term Notes, Series A, Floating Rate Notes Due 2029. |
| January 1, 2029 | Effective date for ASU 2025-10 (Government Grants). |
| October 15, 2029 | Earliest optional redemption date for Series Q Preferred Stock. |
Recommendation
strong buyMorgan Stanley delivered exceptional financial results in 2025, with significant increases in net revenues, net income, and diluted EPS, alongside improved efficiency and strong capital ratios. The firm exceeded its ROTCE goal, demonstrating robust operational performance across all segments, particularly in Wealth Management and Institutional Securities. The increased common stock dividend and substantial share repurchase authorization signal strong confidence from management and a commitment to shareholder returns. While legal and regulatory challenges persist, the firm's proactive management of these risks and its strong liquidity position mitigate immediate concerns. The overall trajectory and strategic execution warrant a strong buy recommendation for long-term investors.
Keywords
Morgan Stanley, Financial Services, Investment Banking, Wealth Management, Investment Management, SEC Filing, 10-K, Financial Performance, Capital Ratios, Risk Management, Cybersecurity, Regulatory Compliance, Credit Risk, Market Risk, Liquidity, ESG, Climate Risk, Share Repurchase, Dividends, Preferred Stock, Debt Securities, Global Medium-Term Notes, SOFR, LIBOR, Basel III, TLAC, SPOE, Antitrust, Litigation, Earnings, Revenue, EPS, ROE, ROTCE
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.